ARCH Venture Partners IX, LLC

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Chicago, IL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
ARCH Venture Partners IX, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Robert Nelsen, Managing Director
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for ARCH Venture Partners IX, LLC

Form 4 holding 10%+ Owner

Beam Therapeutics Inc.

Security class
Common Stock
Shares / value
2,921,519
Estimated value
$77,186,532
Report date
30 Jun 2021
Price
$26.42
Ownership
Indirect
Form 4 holding 10%+ Owner

Beam Therapeutics Inc.

Security class
Common Stock
Shares / value
28,111
Estimated value
$742,693
Report date
30 Jun 2021
Price
$26.42
Ownership
Direct
Form 4 holding 10%+ Owner

Vir Biotechnology, Inc.

Security class
Common Stock
Shares / value
61,160
Estimated value
$93,575
Report date
06 Sep 2022
Price
$1.53
Ownership
Indirect
Form 4 holding 10%+ Owner

Vir Biotechnology, Inc.

Security class
Common Stock
Shares / value
30,570
Estimated value
$46,772
Report date
06 Sep 2022
Price
$1.53
Ownership
Direct

Insider Reports Filed by ARCH Venture Partners IX, LLC

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .